• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Former Masimo CEO Joe Kiani plans to sue board members

Former Masimo CEO Joe Kiani plans to sue board members

March 4, 2025 By Danielle Kirsh

Masimo CEO Joe Kiani
Masimo founder, Chair and CEO Joe Kiani [Image courtesy of Masimo]
Former Masimo CEO Joe Kiani submitted a Private Attorneys General Act (PAGA) notice in a move to sue Masimo board members.

In a February 28 letter to the California Labor & Workforce Development Agency (LWDA), Kiani alleges that Masimo, under the direction of investment firm Politan Capital Management and its allies on the board, “resorted to knowing and willful violations” of California labor codes to avoid paying Kiani after his resignation in October 2024. His claims include unpaid wages, stock options, restricted stock units (RSUs), and a $35 million lump sum payment outlined in his employment agreement.

Kiani seeks over $100 million in statutory penalties from six Politan Capital Management-affiliated board members, including Quentin Koffey, Michelle Brennan, Darlene Solomon, William Jellison, Wendy Lane and Timothy Scannell.

Masimo declined to comment in response for now.

A spokesperson for Kiani told MassDevice:

“Mr. Kiani took this action in response to the scorched earth and bad faith campaign by the Politan-led board of Masimo to avoid paying him what he is contractually owed after being forced out of the company he founded 35 years ago in his garage. In addition to the lawsuit he brought to enforce the terms of his employment agreement, Mr. Kiani is seeking to hold the company and each of its six Politan-affiliated directors accountable for their unlawful conduct under California’s Private Attorneys General Act. These claims carry potential statutory penalties of more than $100 million, with 65% of any recovery payable to the State of California.”

The dispute follows Politan’s 2022 acquisition of a 9% stake in Masimo, which Kiani alleges led to a hostile takeover that resulted in his resignation. He claimed that the board manufactured a pretextual “for cause” termination to avoid paying his severance and other benefits.

Kiani has already filed a lawsuit against Masimo in Orange County Superior Court and now seeks penalties under California’s Private Attorney General Act (PAGA) for multiple violations of state labor laws. If the LWDA does not take action within 65 days, he intends to proceed with the claims on behalf of the state.

Masimo also filed a lawsuit against Kiani and investment firm RTW Investments late last year, accusing them of illegally manipulating a recent shareholder vote. The suit, filed in the New York Southern District federal court, alleges Kiani and RTW orchestrated an “empty voting” scheme to boost RTW’s voting power without corresponding economic risk. The company claims the scheme played out to keep Kiani on Masimo’s board.

In a recent SEC 10-K legal filing, Masimo said the following regarding its ongoing disputes with Kiani:

We believe that the company ultimately will prevail in its dispute with Mr. Kiani, for three primary reasons. First, as noted, the company asserts in the Kiani Delaware Litigation that numerous provisions in the Amended Employment Agreement are invalid and unenforceable as a matter of Delaware law. Indeed, in a prior litigation concerning the Amended Employment Agreement, the Delaware Court of Chancery, in a preliminary ruling, questioned the validity of some of the same provisions that the company challenges in the Kiani Delaware Action. Second, the company asserts that the Special Payment is invalid on the ground that it is an unenforceable penalty that fails to reflect an estimate of any actual damages incurred by Mr. Kiani. Third, because the company terminated Mr. Kiani’s employment for cause, under the plain terms of the Amended Employment Agreement, Mr. Kiani is not entitled to any severance payments as a result of that termination. If the company prevails in its litigation with Mr. Kiani, Mr. Kiani will not receive any of the benefits to which he has claimed he is entitled.

Meanwhile, Masimo has started out 2025 by upping its full-year earnings guidance under new CEO Katie Szyman — who led Edwards Lifesciences’ Critical Care business for over a decade.

Filed Under: Business/Financial News, Featured, Legal News, Wall Street Beat Tagged With: Masimo, Politan Capital Management

More recent news

  • Medtronic announces a company president
  • Medtronic nets CE mark for Vitalis family of conduction system pacemakers
  • E2’s pulmonary embolism platform claims two FDA clearances
  • Resmed to launch AirTouch F40 full-face fabric CPAP mask in US
  • Paradromics taps Siemens Healthineers to develop scalable BCI imaging

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy